DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Asselah T, Kowdley KV, Zadeikis N. et al.
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.

Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 2018;
16: 417-426

Download Bibliographical Data

Access:
Access: